SHERRIE LUCERO: Open Payments
NPI 1841825825 · NORTH LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,568 in 74 payments from 14 companies in 2025. Trend: 2023 $3,727 · 2024 $3,928 · 2025 $1,568
Food & beverage: $1,568
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $350 |
| Janssen Pharmaceuticals, Inc | 9 | $301 |
| Otsuka America Pharmaceutical, Inc. | 18 | $234 |
| Alkermes, Inc. | 7 | $156 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 4 | $90 |
| Axsome Therapeutics, Inc. | 3 | $82 |
| ABBVIE INC. | 3 | $70 |
| Lundbeck LLC | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
Products named: INGREZZA, REXULTI, SPRAVATO, ARISTADA, INVEGA SUSTENNA, COBENFY, FANAPT, Auvelity.
Industry payments across NV — which companies pay providers there.
